Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.
人类对抗癌症的征途遥远而艰辛，每一次新疗法出现，都如同一道曙光，带来希望。
近年来被广泛用于癌症治疗的免疫疗法不断推陈出新，这一次，从日本传来了好消息……
自我免疫力抗癌细胞 癌症临床新疗法
莲见贤一郎医生（Dr.Kenichiro Hasumi）在8年前发现了人类自愈疫苗疗法（Human Initiated Therapeutic Vaccine，简称HITV），为末期癌症患者带来了希望。
人类自愈疫苗疗法是一项以免疫学作为基础的癌症疗法，主要针对那些癌症治疗失败后的末期癌症患者。
加强细胞免疫力
HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.
Publications, News & Events